Importantly, pharmacological inhibition of NAMPT and PARP1 using FK886 and Olaparib, respectively, reversed Adi‐CM‐induced cisplatin resistance and restored cisplatin sensitivity in osteosarcoma cells, DIO mouse models, and patient‐derived organoids. The gene discussed is NAMPT; the disease is osteosarcoma.